Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino Acid (15) Peritoneal Dialysis Solution vs Glucose Dialysate in Malnourished CAPD Patients
ChiCTR2400088333Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2024
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amino acid peritoneal dialysis solution in end-stage kidney disease (ESKD), hypoalbuminemia and protein-calorie malnutrition (PCM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Serum albumin (ALB). Started Aug 2024; status: recruiting.
02
Drugs
amino acid peritoneal dialysis solution
03
Conditions
end-stage kidney disease (ESKD)hypoalbuminemiaprotein-calorie malnutrition (PCM)
Beyond the preview
Go deeper on ChiCTR2400088333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088333.